Medtronic SynchroMed II infusion pump – hazard alert

These implantable, programmable medical devices deliver medicines directly into the spinal fluid for the treatment of chronic pain or muscle spasticity.
It has been identified that these infusion pumps have the potential for over-infusion, where the delivery rate exceeds the programmed rate (by more than 14.5 per cent) producing a risk of overdose. There is also the potential for the return of underlying symptoms and/or withdrawal symptoms if the pump empties earlier than expected.
Clinicians treating patients with these devices should refer their patients to the surgeon or neurologist managing these devices if they have any questions.


Find more information here.
Copyright © Australian and New Zealand College of Anaesthetists.